MedPath

Nasal Mask Kit in Gastrointestinal Endoscopy

Not Applicable
Recruiting
Conditions
Gastric Polyp
Colon Polyp
Hypoxia
Gastric Cancer
Colon Cancer
Esophageal Cancer
Interventions
Device: nasal mask oxygen kit
Device: regular nasal cannula
Registration Number
NCT05405530
Lead Sponsor
RenJi Hospital
Brief Summary

Hypoxia is the most common adverse event in gastrointestinal endoscopes sedated with propofol. The nasal mask oxygen kit has good sealing to ensure an adequate oxygen supply and is convenient and economical.The aim of this randomized study was to determine whether the nasal mask oxygen kit reduces the incidence of hypoxia in gastrointestinal endoscopes procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1200
Inclusion Criteria
  • 18≤ Age ≤60
  • patients undergoing combined gastroendoscopy and colonoscopy procedure
  • patients signed informed consent form
  • ASA classification I-II
  • Estimated procedure time <=45min
Exclusion Criteria
  • Coagulation disorders or a tendency of nose bleeding
  • Diagnosed heart disease (heart failure, angina, myocardial infarction, arrhythmia, etc.)
  • Diagnosed chronic obstructive pulmonary disease or current other acute or chronic lung disease requiring supplemental chronic or intermittent oxygen therapy)
  • hypoxia (SpO2< 90 % )
  • Upper respiratory tract infection
  • increased intracranial pressure
  • Fever (core body temperature >37.5 ℃)
  • Pregnancy, breastfeeding, or positive pregnancy test
  • Emergency procedure or surgery
  • Multiple trauma
  • Allergy to propofol or tape and adhesives
  • BMI<18.5 or BMI>30

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
nasal mask oxygen groupnasal mask oxygen kitIn this group, patients use the nasal mask oxygen kit for oxygenation.
regular nasal cannula groupregular nasal cannulaIn this group, patients use the regular nasal cannula for oxygenation.
Primary Outcome Measures
NameTimeMethod
The incidence of hypoxiaPatients will be followed for the duration of hospital stay, an expected average about 2 hours]

(75% ≤ SpO2 \< 90% for \<60 s)

Secondary Outcome Measures
NameTimeMethod
The incidence of severe hypoxiaPatients will be followed for the duration of hospital stay, an expected average about 2 hours

(SpO2 \< 75% or 75% ≤ SpO2 \< 90% for \>/=60 s)

The incidence of other adverse eventsPatients will be followed for the duration of hospital stay, an expected average about 2 hours]

Other adverse events recorded by tools proposed by the World Society of Intravenous Anesthesia International Sedation Task Force

The incidence of sub-clinical respiratory depressionPatients will be followed for the duration of hospital stay, an expected average about 2 hours]

(90% ≤ SpO2 \< 95%)

Trial Locations

Locations (3)

Henan Provincial People's Hospital

🇨🇳

Zhengzhou, Henan, China

First Affiliated Hospital of Kunming Medical University

🇨🇳

Kunming, Yunnan, China

Renji Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath